Steinberg AD , Steinberg SC . Long term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisolone alone . Arthritis Rheum1991; 34 (8): 945–950 .
2.
Balow JW , et al. Lupus nephritis . Ann Intern Med1987; 106: 79–94 .
3.
Boumpas DT , et al. Controlled trial of pulse methyl prednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis . Lancet1992; 340: 741–745 .
4.
Levey AS , et al.. The Lupus Nephritis Collaborative Study Group. Progression and remission of renal disease in the lupus nephritis collaborative study . Ann Intern Med1992; 116: 114–123 .
5.
Wang CL , Wang F , Bosco JJ . Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus . Lupus1995; 4: 11–14 .
6.
Belmont HM , Storch M , Buyon J . Abramson S . New York University/Hospital for Joint Disease experience with intravenous cyclophosphamide treatment: efficacy in steroid unresponsive lupus nephritis . Lupus1995; 4: 104–108 .
7.
Montz FJ , Wolff AJ , Gambone, JC . Gonadal protection and fecundity rates in cyclophosphamide-treated rats . Cancer Res1991; 51: 2124–2126 .
8.
Klippel JH . Cyclophosphamide: ovarian and other toxicities . Lupus1995; 4: 1–2 .
9.
Boumpas DT et al. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy . Ann Intern Med1993; 119: 366–369 .
10.
Langevitz P , Klein L , Pras M . Many A . The effect of cyclophosphamide pulses on fertility in patients with lupus nephritis . Am J Reprod Immunol1992; 28: 157–580 .
11.
Roubenoff R . Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertility . Semin Arthritis Rheum1988; 18 (2): 88–110 .
12.
Karashima T , Zalatni A , Schally AV . Protective effects of analogs of luteinizing hormone-releasing hormone against chemotherapy-induced testicular damage in rats . Proc Natl Acad Sci USA1988; 85: 2329–2333 .
13.
Tummon IS , et al. A randomized, prospective comparison of endocrine changes induced with intranasal leuprolide or danazol for treatment of endometriosis . Fertil Steril1989; 51: 390–394 .
14.
Ataya KM et al. A luteinizing hormone-relating agonist for the prevention of chemotherapy-induced ovarian follicular loss in rats . Cancer Res1985; 45: 2651–2656 .
15.
Ataya KM , Rao LV , Lawrence E , Kimmel R . Luteinizing hormone releasing hormone agonist inhibits cyclophosphamide induced ovarian follicular depletion in rhesus monkeys . Biol Reprod1995; 52: 365–372 .
16.
Ataya KM , Pydyn E , Ramahi-Ataya , Orton CG . Is radiation induced ovarian failure in rhesus monkeys preventable by luteinizing hormonexs releasing hormone agonists?J Clin Endocrinol Metals1995; 80 (3): 790–794 .
17.
Dlugi AM , Miller JD , Knittle J , Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study . Fertil Steril1990; 54: 419–426 .
18.
Lemay A , Surrey ES , Friedman AJ . Extending the use of gonadotropinreleasing hormone agonists. The emerging role of steroid and nonsteroid agents . Fertil Steril1994; 61 (1): 21–34 .
19.
Friedman AJ , et al. for the Leuprolide Study Group. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multi center study . Obstet Gynecol1991; 77: 720–725 .
20.
Fogelman, I . Gonadotropin-releasing hormone agonists and the skeleton . Fertil Steril1992; 57: 715–724 .
21.
Scialli AR , Jestila KJ , Simon JA . Leuprolide acetate and bone mineral density measured by quantitive radiography . Fertil Steril1993; 59 (3): 674–676 .
22.
Johansen JS , et al. The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism . J. Clin. Endocrinol Metab1988; 67: 701–706 .
23.
Barbieri RL , Friedman AJ . Gonadotropin Releasing Hormone Analogs. New York: Elsevier Science , 51, 1991.
Tobback C , Hugh S , Foote RH . A procedure for cyropreservation of hamster oocytes yielding highly conserved oocytes suitable for sperm penetration tests . Fertil Steril1991; 55 (1): 184–188 .
26.
Hammitt DG . Conditions of oocyte storage and use of noninseminated as compared with inseminated non fertilized oocytes for the hemizona assay . Fertil Steril1993; 60: 131–163 .
27.
Harp R et al. Cryopreservation of murine ovarian tissue . Cryobiol1994; 31: 336–343 .
28.
Gook DA , Osborn SM , Bourne H , Johnson WIH . Fertilization of human oocytes following cyropreservation: normal karyotypes and absence of stray chromosomes . Hum Reprod1994; 9 (4): 684–691 .
29.
Hunter JL . Cryopreservation of human prophase I oocytes collected from unstimulated follicles . Fertil Steril1994; 61 (6): 1077–1082 .
30.
Toth TL et al. Cryopreservation of human prophase I oocytes collected from unstimulated follicles. Fertilization and in vitro development of cryopreserved human prophase I oocytes . Fertil Steril1994; 61 (5): 891–894 .
31.
Gutmann JN . Cancer and infertility . Infertil Reprod Med Clin North Am1996; 7 (3): 935–952 .
32.
Ataya KM , Valeriote FA , Ramahi-Ataya AJ . Effect of cyclophosphamide on the immature rat ovary . Cancer Res1989; 49: 1660–1664 .
33.
Hochberg MC . Bisphosphonates in the treatment of osteoporosis . J Clin Rheumatol1997; 3: 537–539 .
34.
Petri M , Robinson C . Oral contraceptives and systemic lupus erythematosus . Arthritis Rheum1997; 40 (5): 797–803 .
35.
Arden NK , Lloyd ME , Spector TD , Hughes GRV . Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE) . Lupus1994; 3: 11–13 .
36.
Buyon JP et al Can women with systemic lupus erythematousus safely use exogenous estrogens?J Clin Rheumatol1995; 1 (4): 205–212 .
37.
Leather AT , Studd JWW , Watson NR , Holland EFN . The prevention of bone loss in young women treated with GNRHa analogues with ‘add back’ estrogen therapy . Obstet Gynecol1993; 81 (1): 104–107 .
38.
Laufer MR , et al. Inducing amenorrhea during bone marrow transplantation . J Reprod Med1997; 42 (9): 537–541 .
39.
Damario MA , Rock JA . Gosrelin (Zoladex) versus danazol for endometriosis: the North American experience . B J Obstet Gyanecol1994; 101 (S10): S13–S18 .
40.
Laufer MR , Rein MS . Treatment of abnormal uterine bleeding with gonadotropin-releasing hormone analogues . Clin Obstet Gynecol1993; 36 (3): 668–678 .
41.
Henzl MR . Gonadotropin-releasing hormone and its analogues: from laboratory to bedside . Clin Obstet Gynecol1993; 36 (3): 617–635 .
42.
Newton H et al. Low temperature storage and grafting of human ovarian tissue . Hum Reprod1996; 11 (7): 1487–1491 .
43.
Zhang J et al. Extracorporeal development and ultrarapid freezing of human fetal ova . J Assist Reprod Gent1995; 12 (6): 361–368 .
44.
Dawood MY , Ramos J , Khan-Dawood FS . Depot Leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin . Fertil Steril1995; 63 (6): 1177–1183 .
45.
Fogelman I , et al. Goserelin (Zoladex) and the skeleton . Br J Obstet Gynaecol1994; 101 (S10): S19–S23 .
46.
Chapman RM , Sutcliffe SB . Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkins disease . Blood1981; 58 (4): 849–851 .
47.
Gradishar WJ , Schilsky RL . Ovarian function following radiation and chemotherapy for cancer . Semin Oncol1989; 16 (5): 425–436 .
48.
Bermas BL , Hill JA . Effects of immunosuppressive drugs during pregnancy . Arthritis Rheum1995; 38 (12): 1722–1732 .
49.
Hovatta O , et al. Cryopreservation of human ovarian tissue using dimethylsulphoxide and propanediol-sucrose as cryoprotectants . Hum Reprod1996; 11 (6): 1268–1272 .
50.
Candy CJ , Wood MJ Whittingham DG . Follicular development in cryopreserved marmoset ovarian tissue after transplantation . Hum Reprod1995; 10 (9): 2334–2338 .
51.
Cox SL , Shaw J , Jenkin G . Transplantation of cryopreserved fetal ovarian tissue to adult recipient in mice . J Reprod Fertil196; 107: 315–322 .
52.
Gosden RG , Baird DT , Wade JC , Webb R . Restoration of fertility to oophorectomized sheep by ovarian autografts stored at — 196°C . Human Reprod1994; 9 (4): 597–603 .
53.
Ramsey-Goldman R , et al. Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs . J. Rheumatol1993; 20 (4): 1152–1157 .
54.
Kovarsky J . Clinical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic diseases . Semin Arthritis Rheum1983; 12 (4): 359–371 .
55.
Sanders JE et al. Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation . Transplantation1983; 36 (3): 252–255 .
56.
Clements PJ , Davis, J . Cytotoxic drugs: their clinical application to the rheumatic diseases . Semin. Arthritis Rheum1986; 15 (4): 231–254 .
57.
Warne GL , Fairley KF , Horbs JB , Martin FIR . Cyclophosphamideinduced ovarian failure . N Eng J Med1973; 289: 1159–1162 .
58.
Rivkees SA , Crawford JD . The relationship of gonadal activity and chemotherapy-induced gonadal damage . JAMA1988; 259: 2123–2125 .
59.
Cann CE et al. Reversible bone loss is produced by the GNRHa agonist nafarelin. In: Cohn DV , Martin TJ , Meunier A (eds). Calcium Regulation and Bone Metabolism. Amsterdam: Elsevier Science , 1987, 123–127.
60.
Lahita RG , Bucala R , Bralow HL , Fishman J . Determination of 16 alpha-hydroxyesterone by radioimmunoassay in systemic lupus erythematosus . Arthritis Rheum1985; 18: 1122–1127 .
61.
Sanchez-Guerrero J , et al. Past use of oral contraceptives and the risk of developing systemic lupus erythematosus . Arthritis Rheum1997; 40 (5): 804–808 .
62.
Martin F , et al. Side effects of intravenous cyclophosphamide pulse therapy . Lupus1997; 6: 254–257 .
63.
Koyama H , et al. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer . Cancer1977; 39: 1403–1409 .
64.
Polak de Fried E , et al. Pregnancy after human donor oocyte cryopreservation and thaw in association with intracytoplasmic sperm injection in a patient with ovarian failure . Fertil Steril1998; 69 (3): 555–557 .
65.
Ataya KM et al. Inhibition of rat ovarian [3H] thymidine uptake by luteinizing hormone releasing hormone agonists: a possible mechanism for preventing damage by cytotoxic agents . Cancer Res1988; 48: 7252–7256 .
66.
Blumenfeld Z , et al. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotropinreleasing hormone agonist in parallel to chemotherapy . Hum Reprod1996; 11: 1620–1626 .
